Full-Time

Senior Scientist

Computational Chemistry

Confirmed live in the last 24 hours

Flagship Pioneering

Flagship Pioneering

201-500 employees

Biotechnology firm creating health and sustainability solutions

No salary listed

Senior

Cambridge, MA, USA

Category
Computational Biology
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Scikit-learn
Python
Pytorch
Machine Learning
Pandas
NumPy
Data Analysis
Requirements
  • Ph.D. in Computational Chemistry, Medicinal Chemistry, Biochemistry, or a related discipline and 5+ years of professional experience preferably with small molecule drug discovery or preclinical development industry experience, or master's degree and 6+ years of industry experience.
  • Extensive knowledge and experience in the design and implementation of computational and engineering solutions applied to high throughput screening. Experience with DNA-encoded library screening is a plus.
  • Proficiency in Python and familiarity with python packages (e.g., Scikit-learn, Pandas, NumPy, and equivalent tools) for data science.
  • Experience in data mining, database management and design, statistical analysis of large data sets.
  • Experience in PyTorch or equivalent tools.
  • Experience integrating with ELN and LIMS systems, adhering to robust data capture practices and ensuring team compliance.
  • Excellent communication and presentation skills, with the ability to convey complex scientific concepts to both technical and non-technical audiences.
  • Strong analytical skills with the ability to interpret complex datasets and derive meaningful insights.
  • Proven ability to work effectively in a collaborative team environment and manage multiple projects simultaneously.
  • Resourceful problem solver and self-starter.
Responsibilities
  • Serve as inaugural member of the Computational chemistry team, establishing core infrastructure and workflows.
  • Lead, design and execute processes for DEL data integration, including DEL compound management and metadata capture of experiments.
  • Drive development and implementation of new computational tools and methodologies (e.g., machine learning models, data exploration, visualization) to strengthen DEL data analysis.
  • Serve as a key contributor with experimental teams to drive design of robust DEL experiments (e.g., designs, controls, library compositions).
  • Analyze and interpret data from computational experiments, and provide insights and recommendations to guide decision-making.
  • Manage relationships with vendors, CROs, and consultants for external workflows and input.
  • Present findings to the team, provide strategic input on project direction, while ensuring rapid turnaround of analysis to drive achievement of key project goals.
  • Act as a thought leader for advancements in the field of computational chemistry, applying this knowledge to new and ongoing projects.
Desired Qualifications
  • Experience in computational chemistry drug design and optimization approaches including ligand-based and structure-based (Autodock, rDock, or similar).
  • Experience with AWS or similar
  • Experience in protein degradation and/or the development of protein degraders or other heterobifunctional molecules.
  • Prior industry experience.

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Size

201-500

Company Stage

N/A

Total Funding

$10.5B

Headquarters

Cambridge, Maryland

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Flagship's collaboration with Cambridge University accelerates biotech research and innovation.
  • Lila Sciences' AI platform automates scientific discovery, enhancing research efficiency.
  • Etiome's focus on preemptive healthcare taps into a growing market trend.

What critics are saying

  • Lila Sciences faces competition in the crowded AI-driven scientific discovery market.
  • Regulatory scrutiny may delay Etiome's preemptive healthcare technology market entry.
  • Inari Agriculture's valuation jump raises potential overvaluation concerns for Flagship.

What makes Flagship Pioneering unique

  • Flagship Pioneering creates first-in-category ventures transforming health and sustainability.
  • The firm combines science, entrepreneurialism, and capital management in a single enterprise.
  • Flagship's evolutionary methodology navigates from unreasonable propositions to transformational outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Flexible Work Hours

Company News

VC News Daily
Apr 25th, 2025
Etiome Launches With $50M

CAMBRIDGE, MA, Etiome has announced a $50 million financing round from Flagship Pioneering.

Health Technology Insights
Apr 24th, 2025
Flagship Pioneering Unveils Etiome to Pioneer Preemptive Healthcare

Flagship Pioneering, the bioplatform innovation company, unveiled Etiome, a company redefining how Health Technology Insights.

GlobeNewswire
Mar 19th, 2025
Ampersand Biomedicines Raises Series B Financing and Highlights Pipeline Advancements

$65 million in Series B funding secured from investors, including founder Flagship Pioneering and Eli Lilly & Company Two lead programs in...

BioPharmaTrend
Mar 11th, 2025
Lila Sciences Raises $200M to Automate Scientific Discovery with AI and Robotics

Flagship Pioneering has announced the launch of Lila Sciences, a company developing an AI-based platform designed to automate scientific experimentation and discovery.

PR Newswire
Mar 10th, 2025
Flagship Pioneering Unveils Lila Sciences to Build Superintelligence in Science

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today unveiled Lila Sciences, a company building the world's first scientific...